Concurrent RUNX1::MECOM and RUNX1::PRDM16 Fusions from a Novel Genomic Breakpoint: First Report of a Dual-Fusion Mechanism in Acute Myeloid Leukemia.

Chen S, Wu S, Zhang J, Qiang X, Liu S, Yang W, Peng X, Zhang X, Ren J, Zhang C

Open source

DOI
10.2147/ott.s635500
Published
2026
Container
OncoTargets and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/ott.s635500,
  title = {Concurrent RUNX1::MECOM and RUNX1::PRDM16 Fusions from a Novel Genomic Breakpoint: First Report of a Dual-Fusion Mechanism in Acute Myeloid Leukemia.},
  author = {Chen S and Wu S and Zhang J and Qiang X and Liu S and Yang W and Peng X and Zhang X and Ren J and Zhang C},
  year = {2026},
  journal = {OncoTargets and therapy},
  doi = {10.2147/ott.s635500},
  url = {https://doi.org/10.2147/ott.s635500}
}

RIS

TY  - JOUR
TI  - Concurrent RUNX1::MECOM and RUNX1::PRDM16 Fusions from a Novel Genomic Breakpoint: First Report of a Dual-Fusion Mechanism in Acute Myeloid Leukemia.
AU  - Chen S
AU  - Wu S
AU  - Zhang J
AU  - Qiang X
AU  - Liu S
AU  - Yang W
AU  - Peng X
AU  - Zhang X
AU  - Ren J
AU  - Zhang C
PY  - 2026
JO  - OncoTargets and therapy
DO  - 10.2147/ott.s635500
UR  - https://doi.org/10.2147/ott.s635500
ER  - 

APA

S, C., S, W., J, Z., X, Q., S, L., W, Y., X, P., X, Z., J, R., & C, Z. (2026). Concurrent RUNX1::MECOM and RUNX1::PRDM16 Fusions from a Novel Genomic Breakpoint: First Report of a Dual-Fusion Mechanism in Acute Myeloid Leukemia.. OncoTargets and therapy. https://doi.org/10.2147/ott.s635500

Source records